Source: Eur Respir J, 58 (3) 2100839; 10.1183/13993003.00839-2021
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Simone Villa, Elisa Tagliani, Emanuele Borroni, Paola Francesca Castellotti, Maurizio Ferrarese, Arash Ghodousi, Anna Lamberti, Sabrina Senatore, Marino Faccini, Daniela Maria Cirillo, Luigi Ruffo Codecasa. Outbreak of pre- and extensively drug-resistant tuberculosis in northern Italy: urgency of cross-border, multidimensional, surveillance systems. Eur Respir J, 58 (3) 2100839; 10.1183/13993003.00839-2021

Member's Comments

No comment yet.

Related content which might interest you: Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk Source: Eur Respir J 2012; 39: 1425-1431 Year: 2012 Multidrug-resistant and extensively drug resistance tuberculosis has a strong public health and economical impact in the Republic of Moldova Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 HIV screening in tuberculosis patients, in the northern region of Portugal Source: International Congress 2015 – Screening strategies in TB Year: 2015 Rifampicin-resistant tuberculosis (RR-TB) in eastern Europe Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Pre-immigration screening process and pulmonary tuberculosis among Ethiopian migrants in Israel Source: Eur Respir J 2008; 32: 413-418 Year: 2008 The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results Source: Eur Respir J 2011; 38: 1374-1381 Year: 2011 Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia Source: Eur Respir J 2012; 40: 133-142 Year: 2012 Comparison of tuberculosis surveillance systems in low-incidence industrialised countries Source: Eur Respir J 2008; 32: 1616-1624 Year: 2008 High initial multidrug-resistant tuberculosis rate in Buenaventura, Colombia: a public–private initiative Source: Eur Respir J 2012; 40: 1569-1572 Year: 2012 Programmatic management of drug resistance tuberculosis: Outcome analysis of 200 patients in western part of Rajasthan, India Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement Source: Eur Respir J 2012; 40: 1081-1090 Year: 2012 Multidrug-resistant tuberculosis and HIV infection in Eastern Europe: Two overlapping epidemics Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012 Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe Source: Eur Respir J, 57 (1) 2003890; 10.1183/13993003.03890-2020 Year: 2021 Cameroon's multidrug-resistant tuberculosis treatment programme jeopardised by cross-border migration Source: Eur Respir J 2016; 47: 686-688 Year: 2016 Impact of the SARS-CoV-2 epidemic on tuberculosis treatment outcome in Northern Italy Source: Eur Respir J, 56 (4) 2002665; 10.1183/13993003.02665-2020 Year: 2020 Success in putting TB epidemic under control, implementing DOTS-strategy in the penitentiary system of Tomsk Oblast, Western Siberia, Russia Source: Eur Respir J 2001; 18: Suppl. 33, 313s Year: 2001 Childhood tuberculosis in Israel: epidemiological trends and treatment outcomes, 1999–2010 Source: Eur Respir J 2013; 41: 1157-1162 Year: 2013 Treatment adherence factors impact on the evolution of tuberculosis cases in Brasov District, Romania Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010 Risk factors for drug-resistant tuberculosis in the north of Portugal Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011